Bautista-Aguilera, Ó.M.; Ismaili, L.; Chioua, M.; Andrys, R.; Schmidt, M.; Bzonek, P.; Martínez-Grau, M.Á.; Beadle, C.D.; Vetman, T.; López-Muñoz, F.;
et al. Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy. Int. J. Mol. Sci. 2020, 21, 3913.
https://doi.org/10.3390/ijms21113913
AMA Style
Bautista-Aguilera ÓM, Ismaili L, Chioua M, Andrys R, Schmidt M, Bzonek P, Martínez-Grau MÁ, Beadle CD, Vetman T, López-Muñoz F,
et al. Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences. 2020; 21(11):3913.
https://doi.org/10.3390/ijms21113913
Chicago/Turabian Style
Bautista-Aguilera, Óscar M., Lhassane Ismaili, Mourad Chioua, Rudolf Andrys, Monika Schmidt, Petr Bzonek, María Ángeles Martínez-Grau, Christopher D. Beadle, Tatiana Vetman, Francisco López-Muñoz,
and et al. 2020. "Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy" International Journal of Molecular Sciences 21, no. 11: 3913.
https://doi.org/10.3390/ijms21113913
APA Style
Bautista-Aguilera, Ó. M., Ismaili, L., Chioua, M., Andrys, R., Schmidt, M., Bzonek, P., Martínez-Grau, M. Á., Beadle, C. D., Vetman, T., López-Muñoz, F., Iriepa, I., Refouvelet, B., Musilek, K., & Marco-Contelles, J.
(2020). Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences, 21(11), 3913.
https://doi.org/10.3390/ijms21113913